Conjugated Polymer Nanoparticles: Innovative Designs for Photodynamic and Photothermal Therapy in Cancer and Bacterial Infections—Preclinical Evaluation and Beyond
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 31 May 2025 | Viewed by 178
Special Issue Editor
Interests: nanomedicine; cell therapy; tumor microenvironment; photodynamic therapy; cell targeting
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue delves into the cutting-edge advancements made in utilizing conjugated polymer nanoparticles (CPNs) for photodynamic therapy (PDT) and photothermal therapy (PTT) in the treatment of both cancer and bacterial infections. Highlighting innovative designs and preclinical evaluations, this Special Issue aims to explore the synergy between CPNs' unique properties and their application in combating these formidable diseases. With a focus on novel CPN formulations, surface modifications, and targeting strategies, this Special Issue aims to shed light on the development of highly effective therapeutic modalities. Furthermore, by providing comprehensive preclinical evaluations, including efficacy, safety, and pharmacokinetic profiles, this Special Issue aims to bridge the translational gap between bench and bedside, paving the way for future clinical translation. This interdisciplinary exploration not only underscores the potential of CPNs as versatile theranostic agents but also elucidates their promising role in addressing the growing challenges posed by cancer and antibiotic-resistant bacterial infections.
Dr. Luis Ibarra
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- conjugated polymer nanoparticles
- organic semiconducting materials
- biomedical application
- drug delivery
- preclinical evaluation
- antimicrobial nanoparticles
- antitumoral nanoparticles
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
